The biochemistry of activation of nitroimidazole antibiotics in Mycobacterium tuberculosis

被引：0
|
作者：
Barry, C. E. [1 ]
机构：
[1] NIAID, NIH, Bethesda, MD 20892 USA
来源：
FEBS JOURNAL | 2011年 / 278卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [1] Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis
    Barry, CE
    Boshoff, HIM
    Dowd, CS
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (26) : 3239 - 3262
  • [2] Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis
    Sundarsingh, Joseph Antony T.
    Ranjitha, J.
    Rajan, Aiswarya
    Shankar, Vijayalakshmi
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (09) : 1255 - 1264
  • [3] The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis
    Slayden, RA
    Barry, CE
    MICROBES AND INFECTION, 2000, 2 (06) : 659 - 669
  • [4] Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering
    Lee, Brendon M.
    Harold, Liam K.
    Almeida, Deepak V.
    Afriat-Jurnou, Livnat
    Aung, Htin Lin
    Forde, Brian M.
    Hards, Kiel
    Pidot, Sacha J.
    Ahmed, F. Hafna
    Mohamed, A. Elaaf
    Taylor, Matthew C.
    West, Nicholas P.
    Stinear, Timothy P.
    Greening, Chris
    Beatson, Scott A.
    Nuermberger, Eric L.
    Cook, Gregory M.
    Jackson, Colin J.
    PLOS PATHOGENS, 2020, 16 (02)
  • [5] Predicting nitroimidazole antibiotic resistance mutations in <it>Mycobacterium tuberculosis</it> with protein engineering
    Lee, Brendon
    Almeida, Deepak
    Afriat-Jurnou, Livnat
    Aung, Htin
    Forde, Brian
    Harold, Liam
    Hards, Kiel
    Pidot, Sacha
    Ahmed, Hafna
    Mohamed, Elaaf
    Taylor, Mathew
    West, Nicholas
    Stinear, Timothy
    Greening, Chris
    Beatson, Scott
    Cook, Gregory
    Nuermberger, Eric
    Jackson, Colin
    FASEB JOURNAL, 2020, 34
  • [6] Mycobacterium Tuberculosis Proteases and Implications for New Antibiotics Against Tuberculosis
    Zhao, Quan-ju
    Xie, Jian-ping
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2011, 21 (04): : 347 - 361
  • [7] On the interactions of sensitive and resistant Mycobacterium tuberculosis to antibiotics
    Ibargueen-Mondragon, Eduardo
    Esteva, Lourdes
    MATHEMATICAL BIOSCIENCES, 2013, 246 (01) : 84 - 93
  • [8] In Vitro and In Vivo Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis
    Upton, A. M.
    Cho, S.
    Yang, T. J.
    Kim, Y.
    Wang, Y.
    Lu, Y.
    Wang, B.
    Xu, J.
    Mdluli, K.
    Ma, Z.
    Franzblau, S. G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 136 - 144
  • [9] New carbapenem antibiotics with activity against Mycobacterium tuberculosis and Mycobacterium abscessus
    Thu Nguyen
    Alqurafi, Maha
    Chai, Weirui
    Netherton, Mandy
    Gupta, Rashmi
    Nguyen, Pauline
    Cox, Melina
    Meshram, Byron
    Kim, Jean
    Jacobson, Colton
    Marx, Olivia
    Smriti, Snigdha
    Bennett, Maricka
    Watanabe, Chelsea
    Shi, Angela
    Phung, Linda
    Le, Duyen
    Rohde, Kyle
    Buynak, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [10] Biotin biosynthesis in Mycobacterium tuberculosis: physiology, biochemistry and molecular intervention
    Wanisa Salaemae
    Al Azhar
    Grant W.Booker
    Steven W.Polyak
    Protein & Cell, 2011, 2 (09) : 691 - 695
12345